Benzinga | Nov 5, 2020 07:27AM EST

Teva Pharmaceutical Indus Earlier Reported Q3 Adj. EPS $0.58, Inline, Sales $3.98B Miss $4.07B Estimate

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.58 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $3.98 billion which missed the analyst consensus estimate of $4.07 billion by 2.26 percent. This is a 6.71 percent decrease over sales of $4.26 billion the same period last year.